This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ganapathi, R. Articles by Riegler, F. Search for Related Content PubMed PubMed Citation Articles by Ganapathi, R. Articles by Riegler, F.

Differential Effect of the Calmodulin Inhibitor Trifluoperazine on Cellular Accumulation, Retention, and Cytotoxicity of Anthracyclines in Doxorubicin (Adriamycin)-resistant P388 Mouse Leukemia Cells¹

Research Division, Cleveland Clinic Foundation, Cleveland, Ohio 44106

Calmodulin inhibitors enhance cytotoxic effects of doxorubicin (DOX) in DOX-resistant (P388/DOX) P388 mouse leukemia cells by increasing cellular accumulation and retention of drug. In P388/DOX cells treated for 3 hr, cytotoxic effects (based on colony formation in soft agar) of daunorubicin (DAU) in the presence of trifluoperazine (TFP) were DAU concentration-dependent and enhanced 2- to 100-fold. Additionally, in the presence of TFP, on a molar basis, equitoxic doses of DAU were 4-fold lower than DOX for P388/DOX cells. However, in P388/DOX cells treated for 3 hr with other anthracyclines, except for a slight enhancement in the cytotoxic effects of aclacinomycin A (ACM) with TFP, colony formation in soft agar of cells treated with N-trifluoroacetyladriamycin-14-valerate (AD32) and N-trifluoroacetyladriamycin were similar in the absence and presence of TFP. In DOX-sensitive (P388/S) P388 mouse leukemia cells treated for 3 hr, some enhancement in the cytotoxic effects due to TFP were observed with DAU and DOX but not with ACM, AD32, or N-trifluoroacetyladriamycin. Although accumulation of ACM and AD32 in P388/S and P388/DOX cells was similar and unaffected by TFP, the retention of ACM but not AD32 was enhanced 1.5-fold only in TFP-treated P388/DOX cells. In contrast, DAU accumulation in P388/S cells was 4-fold higher than in similarly treated P388/DOX cells, and the 2- and 4-fold increase due to TFP in the accumulation and retention, respectively, of DAU in P388/DOX cells was not observed in P388/S cells. Results from this study indicate that in P388/DOX cells, the calmodulin inhibitor TFP is more effective with DAU than DOX, significantly less effective with ACM, and ineffective with AD32 and N-trifluoroacetyladriamycin.

¹ Supported by USPHS Grant 1R01 CA35531, awarded by the National Cancer Institute, Department of Health and Human Services, and the Cleveland Foundation.

² To whom requests for reprints should be addressed, at the Research Division, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44106.

Received 1/31/84. Accepted 8/ 8/84.

This article has been cited by other articles:

				A. Krishan, K. S. Sridhar, C. Mou, W. D. Stein, E. Lyubimov, Y.-P. Hu, and H. Fernandez Synergistic Effect of Prochlorperazine and Dipyridamole on the Cellular Retention and Cytotoxicity of Doxorubicin Clin. Cancer Res., April 1, 2000; 6(4): 1508 - 1517. [Abstract] [Full Text]